Introducing a New Polymerase Chain Reaction Panel–Based Cerebrospinal Fluid Evaluation for Encephalitis and Meningitis: Does It Influence Empiric Treatment Duration, Length of Hospital Stay, and Pathogen-Specific Diagnoses? - Report - MDSpire
Advertisement
Introducing a New Polymerase Chain Reaction Panel–Based Cerebrospinal Fluid Evaluation for Encephalitis and Meningitis: Does It Influence Empiric Treatment Duration, Length of Hospital Stay, and Pathogen-Specific Diagnoses?
Evaluation of PCR Panel Impact on Treatment and Hospitalization in CNS Infections
Overview
The introduction of the BioFire FilmArray Meningitis/Encephalitis PCR panel did not significantly reduce the duration of empiric antibiotic or antiviral treatments, nor did it shorten hospital stays or increase pathogen-specific diagnoses in patients with meningitis or encephalitis. Adjusted analyses showed no meaningful differences between PCR-based and culture-based diagnostic pathways.
Background
Central nervous system infections such as meningitis and encephalitis carry high mortality and morbidity, necessitating early empiric treatment. Traditional CSF culture diagnostics have long turnaround times, potentially prolonging broad-spectrum empiric therapy and hospital stays. The BioFire FilmArray Meningitis/Encephalitis Panel offers rapid PCR-based pathogen detection, which has been proposed to improve diagnostic speed and stewardship. However, prior studies were limited by small sample sizes and lacked adjusted analyses.
Data Highlights
Parameter
Culture-Based Pathway
PCR Panel-Based Pathway
Difference (95% CI)
P Value
Median time to cessation of empiric coverage against S. pneumoniae and N. meningitidis (days)
4
3
-1 (0 to 3)
0.16
Median time to cessation of empiric coverage against Herpesviridae (days)
1
1
0 (0 to 1)
0.93
Median time to cessation of empiric coverage against L. monocytogenes (days)
2
2
0 (0 to 3)
0.69
Median length of hospital stay after lumbar puncture (days)
12
10
-2 (0 to 3)
0.86
Proportion with pathogen-specific diagnosis (%)
14.0
15.2
Not significant
0.80
Key Findings
Introduction of the PCR panel did not significantly shorten empiric antibiotic treatment duration against typical bacterial meningitis pathogens (median 3 vs 4 days; P = .16).
Empiric antiviral treatment duration against Herpesviridae remained unchanged at a median of 1 day in both cohorts (P = .93).
Duration of empiric treatment against Listeria monocytogenes was similar between groups (median 2 days; P = .69).
Length of hospital stay after lumbar puncture was not significantly reduced with PCR panel use (median 10 vs 12 days; P = .86).
The proportion of patients with pathogen-specific meningitis or encephalitis diagnoses did not increase with PCR panel introduction (15.2% vs 14.0%; P = .80).
Clinical Implications
Despite the rapid diagnostic capability of the BioFire FilmArray PCR panel, its introduction alone may not reduce empiric treatment duration or hospital length of stay without accompanying stewardship interventions. Clinicians should consider integrating diagnostic results with active antimicrobial stewardship to optimize treatment decisions. Reliance solely on PCR panel availability may not improve clinical outcomes or pathogen identification rates.
Conclusion
The PCR panel-based diagnostic pathway did not significantly impact empiric treatment length, hospitalization duration, or pathogen-specific diagnosis rates in meningitis and encephalitis cases. Further strategies beyond test introduction are needed to enhance clinical management.
References
Author/Source/Year -- Evaluation of a Novel PCR Panel for Analyzing Cerebrospinal Fluid in Cases of Encephalitis and Meningitis
